| abstract |
The present invention is useful as a preventive or therapeutic agent for infectious diseases and cancer, can safely and effectively induce systemic and mucosal immune responses, and is capable of inducing oral mucosa, ocular mucosa, ear mucosa, genital mucosa, Providing a mucosal vaccine composition that can be administered to the pharyngeal mucosa, airway mucosa, bronchial mucosa, lung mucosa, gastric mucosa, intestinal mucosa, or rectal mucosa. SOLUTION: At least one type of antigen and Serratia, Leclercia, Rahnella, Acidicaldus, Acidiphilium, Acidiphatera, Acidocella, Acidomonas, Ciacous, Ceraco, Ceraco A mucosal vaccine composition comprising lipopolysaccharide derived from at least one gram-negative bacterium or a salt thereof. [Selection figure] None |